Laura Itzhaki

Chief Scientific Officer
PolyProx Therapeutics
Laura Itzhaki
Laura has over 20 years’ experience leading academic research in the field of protein engineering. She has a BA in Chemistry (Oxford) and PhD in Biochemistry (Cambridge). From 2003 to 2011 her group was located at the MRC Cancer Cell Unit in Cambridge UK, and she is currently a Professor in the Department of Pharmacology at the University of Cambridge. In 2019, she secured seed finance for PolyProx Therapeutics to develop biotherapeutics harnessing the cell’s quality-control machinery to destroy disease-associated proteins that cannot be targeted by conventional drug modalities. 


No data was found